These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12030505)

  • 21. Executive control of working memory in schizophrenia.
    Oram J; Geffen GM; Geffen LB; Kavanagh DJ; McGrath JJ
    Psychiatry Res; 2005 Jun; 135(2):81-90. PubMed ID: 15923044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships of categorization on tests and daily tasks in patients with schizophrenia, post-stroke patients and healthy controls.
    Josman N; Katz N
    Psychiatry Res; 2006 Jan; 141(1):15-28. PubMed ID: 16352347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Impairment of executive function in elderly patients with major unipolar depression: influence of psychomotor retardation].
    Baudic S; Benisty S; Dalla Barba G; Traykov L
    Psychol Neuropsychiatr Vieil; 2007 Mar; 5(1):65-71. PubMed ID: 17412666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain activation during executive processes in schizophrenia.
    Royer A; Schneider FC; Grosselin A; Pellet J; Barral FG; Laurent B; Brouillet D; Lang F
    Psychiatry Res; 2009 Sep; 173(3):170-6. PubMed ID: 19643585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive functioning in adolescents with schizophrenia spectrum disorders.
    Ueland T; Øie M; Inge Landrø N; Rund BR
    Psychiatry Res; 2004 May; 126(3):229-39. PubMed ID: 15157749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensorimotor and cognitive slowing in schizophrenia as measured by the Symbol Digit Substitution Test.
    Morrens M; Hulstijn W; Van Hecke J; Peuskens J; Sabbe BG
    J Psychiatr Res; 2006 Apr; 40(3):200-6. PubMed ID: 16039670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of recurrent major depressive disorder on behavior and cognitive function in female depressed patients.
    Lampe IK; Sitskoorn MM; Heeren TJ
    Psychiatry Res; 2004 Feb; 125(2):73-9. PubMed ID: 15006430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between measures of dementia severity and observation of daily life functioning as measured with the Assessment of Motor and Process Skills (AMPS).
    Bouwens SF; van Heugten CM; Aalten P; Wolfs CA; Baarends EM; van Menxel DA; Verhey FR
    Dement Geriatr Cogn Disord; 2008; 25(1):81-7. PubMed ID: 18042994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological frontal impairments and negative symptoms in schizophrenia.
    Martino DJ; Bucay D; Butman JT; Allegri RF
    Psychiatry Res; 2007 Aug; 152(2-3):121-8. PubMed ID: 17507100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective memory and executive function in schizophrenia.
    Kondel TK
    Brain Cogn; 2002; 48(2-3):405-10. PubMed ID: 12030477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parsing the components of the psychomotor syndrome in schizophrenia.
    Docx L; Morrens M; Bervoets C; Hulstijn W; Fransen E; De Hert M; Baeken C; Audenaert K; Sabbe B
    Acta Psychiatr Scand; 2012 Oct; 126(4):256-65. PubMed ID: 22360494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal study of symptoms and cognitive function in chronic schizophrenia.
    Hughes C; Kumari V; Soni W; Das M; Binneman B; Drozd S; O'Neil S; Mathew V; Sharma T
    Schizophr Res; 2003 Feb; 59(2-3):137-46. PubMed ID: 12414070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dimensions of premorbid functioning in schizophrenia: a review of neuromotor, cognitive, social, and behavioral domains.
    Schenkel LS; Silverstein SM
    Genet Soc Gen Psychol Monogr; 2004 Aug; 130(3):241-70. PubMed ID: 15819307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using virtual reality to evaluate executive functioning among persons with schizophrenia: a validity study.
    Josman N; Schenirderman AE; Klinger E; Shevil E
    Schizophr Res; 2009 Dec; 115(2-3):270-7. PubMed ID: 19850451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two Novel Psychomotor Tasks in Idiopathic Normal Pressure Hydrocephalus.
    Rossetti MA; Piryatinsky I; Ahmed FS; Klinge PM; Relkin NR; Salloway S; Ravdin LD; Brenner E; Malloy PF; Levin BE; Broggi M; Gavett R; Maniscalco JS; Katzen H
    J Int Neuropsychol Soc; 2016 Mar; 22(3):341-9. PubMed ID: 26817685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurological soft signs and their relationship to cognitive and clinical efficacy of atypical antipsychotics in schizophrenia.
    Das M; Kumari V; Soni W; Ettinger U; Binneman B; Hughes C; Mehrotra R; Sharma T
    Schizophr Bull; 2004; 30(2):241-53. PubMed ID: 15279043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Maudsley Early-Onset Schizophrenia Study: cognitive function in adolescent-onset schizophrenia.
    Kravariti E; Morris RG; Rabe-Hesketh S; Murray RM; Frangou S
    Schizophr Res; 2003 Dec; 65(2-3):95-103. PubMed ID: 14630302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global cognitive decline in schizophrenia with remission of symptoms?
    Barbarotto R; Castignoli G; Pasetti C; Laiacona M
    Brain Cogn; 2001; 46(1-2):29-34. PubMed ID: 11527351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vulnerability to involuntary movements over a lifetime trajectory of schizophrenia approaches 100%, in association with executive (frontal) dysfunction.
    Quinn J; Meagher D; Murphy P; Kinsella A; Mullaney J; Waddington JL
    Schizophr Res; 2001 Apr; 49(1-2):79-87. PubMed ID: 11343867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.